3185 results for «2»
3185 results
Featured Cases - Combined valve interventions (Part 2)
25 Nov 2024 – From PCR London Valves 2024
Explore the cutting-edge field of combined valve interventions in this Featured Cases - Combined Valve Interventions (Part 2) session. Witness real-world case presentations showcasing simultaneous M-TEER and TTVR, transcatheter interventions for aortic and mitral prostheses dysfunction and tricuspid valve disease, India's first double valve-in-valve (mitral and...
Featured Cases - TAVI-in-TAVI (Part 2)
25 Nov 2024 – From PCR London Valves 2024
This session features a collection of compelling clinical cases from PCR London Valves 2024, focusing on the challenges and management of TAVI-in-TAVI procedures. Dive into real-world scenarios where redo TAVI was performed for symptomatic paravalvular leaks, TAV-in-TAV was used to address catastrophic complications, and innovative techniques...
Featured Research - Mitral valve (Part 4)
25 Nov 2024 – From PCR London Valves 2024
Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management
26 Nov 2024 – From PCR London Valves 2024
Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...
Featured Cases - TAVI and co-existent coronary artery disease
25 Nov 2024 – From PCR London Valves 2024
Dive into this comprehensive session featuring selected clinical cases from PCR London Valves 2024, focusing on the management of TAVI and coexistent coronary artery disease. Explore various scenarios, including cases of severe aortic stenosis presented with acute coronary syndrome and cardiogenic shock, lifetime management of CAD...
TAV-in-SAV for surgical bioprosthetic valve failure
26 Nov 2024 – From PCR London Valves 2024
Dive into the intricacies of TAV-in-SAV procedures for failed surgical bioprosthetic valves. Gain a comprehensive understanding of the key information needed to evaluate a failed surgical bioprosthesis before considering a valve-in-valve intervention. Learn strategies to avoid high gradients and patient-prosthesis mismatch, and explore the clinical relevance...
Featured Research - Aortic valve (Part 7)
25 Nov 2024 – From PCR London Valves 2024
Delve into the latest research on aortic valve interventions in this featured session from PCR London Valves 2024. Explore insights on TAVI for small annuli, the assessment of coronary blood flow before and after TAVI, the impact of sarcopenia on TAVI outcomes, and novel CT-guided algorithms...
Featured Cases - Congenital heart disease and younger patients
25 Nov 2024 – From PCR London Valves 2024
Delve into this featured session from PCR London Valves 2024, showcasing selected clinical cases focused on congenital heart disease and younger patients. Explore innovative approaches, such as TEER for common aortic valve in complex congenital heart disease, transcatheter double valve-in-valve replacement in right heart disease, and...
Fostering patient care with calcium management solution
18 Dec 2024 – From GulfPCR-GIM 2024
This sponsored session by Abbott explores the value of intracoronary imaging in managing calcified lesions. Learn how to adopt appropriate procedural strategies, utilize orbital atherectomy for plaque modification, and optimize stent results through the insights gained from a live case presentation and debriefing. Discover how these...
Left main PCI strategies for bifurcations and trifurcations
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this comprehensive session on left main PCI strategies for bifurcations and trifurcations. Discover techniques such as the triple kissing balloon inflation technique in a complex distal LM trifurcation lesion, imaging-guided multivessel PCI to left anterior descending CTO and left main bifurcation, and IVUS-guided PCI to...
Caught between a calcified rock and a hard place
19 Dec 2024 – From GulfPCR-GIM 2024
This session delves into the challenges of managing heavily calcified coronary lesions, particularly in complex scenarios like left main bifurcation angioplasty and in elderly patients with unstable angina. Explore innovative techniques to tackle abrupt vessel closure, situations where rotablation may fall short, and state-of-the-art approaches for...
Unlocking the potential of mitral and tricuspid valves clipping
24 Nov 2024 – From PCR London Valves 2024
This session examines two compelling cases: a 78-year-old woman with paroxysmal atrial fibrillation, chest trauma, an osteoporotic sternum fracture, and NYHA II exertional dyspnoea, and an 82-year-old man with chronic three-vessel coronary artery disease, bradycardic AF, peripheral arterial disease, spinal stenosis, and chronic kidney disease. Through...
Rapid-fire - Transcatheter solutions for rare complications
24 Nov 2024 – From PCR London Valves 2024
Prepare to be captivated by a rapid-fire session showcasing transcatheter solutions for rare and complex cardiovascular complications. Witness the percutaneous closure of a right ventricular pseudo-aneurysm, the treatment of a VSD complicating myocardial infarction, and the management of iatrogenic left ventricular pseudo-aneurysms. Explore innovative approaches to...
Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...
How to implement a successful structural intervention programme
26 Nov 2024 – From PCR London Valves 2024
Embark on a journey to learn how to implement a successful structural intervention program. Discover the essential requirements for building transcatheter valve intervention capabilities, including the necessary equipment, personnel, and training programs. Gain insights on establishing aortic, mitral, and tricuspid intervention programs, as well as creating...
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
How coronary physiology may help in guiding treatment of NSTEMI
23 May 2025 – From EuroPCR 2025
This session explores the utility of coronary physiology in guiding NSTEMI treatment. Topics include ischemia with non-obstructive arteries, QFR quality assessment, FFR-CT impact, revascularization deferral, and sex differences in FFR-guided strategies for acute myocardial infarction with multivessel disease.
Permanent pacing after TAVI
23 May 2025 – From EuroPCR 2025
Explore predictors and mechanisms leading to permanent pacemaker implantation after TAVI. This session reviews electrophysiological intervals, atrial pacing markers, anatomical risk factors, and outcomes associated with new generation transcatheter heart valves.
Best companion's case on intravascular lithotripsy
23 May 2025 – From EuroPCR 2025
Join this session focusing on intravascular lithotripsy in challenging cases, emphasizing device and drug synergy, IVUS guidance, and strategies to avoid exacerbating complications. Clinical cases demonstrate management of tough calcified lesions with novel approaches.
High-risk PCI in TAVI procedures
23 May 2025 – From EuroPCR 2025
This session highlights high-risk PCI in the context of TAVI procedures, including hybrid approaches for aortic stenosis with coronary disease, valve-in-valve scenarios, and unique anatomical challenges such as total situs inversus, emphasizing comprehensive patient management.
